Potential use of IP6 as a novel anticancer drug with antiangiogenic and cytotoxic properties June 14, 2002
Multiple doses of NV-1020 feasible; efficacy demonstrated in pancreatic cancer peritoneal metastasis June 13, 2002
RSS